Back to Search

A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

Grand Junction, CO, 81502
Atlanta, Georgia, 30322
La Mesa, California, 91942
Detroit, Michigan, 48201
Edinburg, Texas, 78539
Search open until 06/29/2025

The main purpose of study is to evaluate the safety and immunogenicity of different dose levels of mRNA-1647 versus control in healthy cytomegalovirus (CMV)-seronegative and CMV-seropositive female and male participants 9 to 15 years of age. In addition,mRNA-1647 will be evaluated in female participants 16 to 25 years as a comparator cohort.

Eligibility

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, learn about Clinical

Ages Eligible for Study Min Age: 9 years - Max Age: 25 years
Sexes Eligible for Study All
Accepts Healthy Volunteers Yes

Visit ClinicalTrials.Gov for more information
Support nonprofit organizations through participating in clinical trials at no cost to you
You may also be interested in
Pelham, Alabama and more
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
Cytomegalovirus Infection Read more
Rockville, Maryland and more
A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults
Seasonal Influenza Read more
Culver City, California
A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression
Major Depressive Disorder Read more